Journal Information
Vol. 45. Issue S3.
XIV Eurasian Hematology Oncology Congress
Pages S43-S44 (October 2023)
Vol. 45. Issue S3.
XIV Eurasian Hematology Oncology Congress
Pages S43-S44 (October 2023)
Pediatric Hematology Abstract CategoriesLeukemia PP 27
Full text access
IS THERE AN ASSOCIATION BETWEEN PULMONARY EMBOLISM AND THE USE OF PEG-ASPARAGINASE IN CHILDREN WITH LEUKEMIA?
Visits
966
Emine Yılmaz Orulluoğlu1, Zühre Kaya1, Merve Yazol2, Büşra Topuz Turkcan1, Serap Kirkiz Kayalı1, Ülker Koçak1,3
1 Gazi University Faculty of Medicine
2 Gazi University Faculty of Medicine, Department of Pediatric Hematology
3 Gazi University Faculty of Medicine, Department of Radiology
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 45. Issue S3

XIV Eurasian Hematology Oncology Congress

More info

We present two leukemic children who developed pulmonary thromboembolism (PTE) after using PEG-asparaginase.The first child, an eight-year-old boy, was diagnosed with T-acute lymphoblastic leukemia (ALL). The second child, a 6-year-old boy, was diagnosed with B-ALL.They developed PTE following induction phases of BFM protocol's.They were given PEG-asparaginase at a dose of 2500IU/m2. Heparin was succesfully used in both cases.Physician may consider prophylactic anticoagulants during induction.

Full text is only available in PDF
Download PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools